Fuan Pharmaceutical's (SHE:300194) wholly-owned subsidiary, Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical, will invest 428 million yuan for the construction of an active pharmaceutical ingredient production base, according to a Shenzhen Stock Exchange filing on Wednesday.
The production base will produce 173.9 tons of raw materials every year.
The facility will include a production plant, a solid warehouse and an office building that will be built with estimated total construction area of 38,800 square meters, the pharmaceutical company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.